ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 447

Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol

Manuel Romero1, Stephen Bruehl2, Gustavo A Reyes del Paso3 and Pablo De la Coba3, 1University Hospital of Jaén, Jaén, Spain, 2Department of Anesthesiology, Vanderbilt University, Nashville, TN, 3Department of Psychology, University of Jaén, Jaén, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: central nervous system involvement, fibromyalgia, pain, psychological status and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pain Mechanisms – Basic and Clinical Science Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

  • In a prior study, the response of pain sensitization by fibromyalgia (FM) patients to a protocol of Slowly Repeated Evoked Pain (SREP)* was strongly associated with clinical pain. However, this protocol needs further investigation regarding its underlying mechanisms and clinical usefulness.

* SREP differs from Temporal Summation of Pain (TSP) in which the frequency of painful stimuli is usually around 0.33 Hz in TSP, whereas it is 10 times slower (0.03 Hz) in SREP.

  • This study explored the central vs. peripheral origin of the pain sensitivity observed in response to SREP protocol when this was applied to patients with chronic pain characterized by central sensitization (FM) vs. characterized by peripheral sensitization (rheumatoid arthritis, RA) vs. healthy controls (HC).

Methods:

  • Fifty-nine patients with FM, 30 with RA, and 50 HC matched in socio-demographic variables participated in this study.
  • Potential group differences of psychological factors were controlled: Clinical Pain (McGill Questionnaire), Anxiety and Depression (HADS), and Catastrophization (CSQ).
  • Participants were instructed in the use of a Visual Analogue Scale (VAS) to assess the pain caused by a pressure algometer on the nail of the third finger.
  • Threshold and tolerance were obtained to calculate the intensity of the pain stimulus individually for each participant. Then, a series of 9 pain stimuli of 5s duration and low-moderate intensity was applied at a 30s interval.
  • SREP sensitization index was quantified as the difference in pain scores between the 9th and 1st painful stimuli.

Results:

  • The repeated measures ANOVA showed a significant increase in subjective pain ratings of the SREP series exclusively for the FM group (see Figure).
  • Logistic regressions revealed an acceptable diagnostic accuracy of SREP index to discriminate between FM & AR and FM & HC, but not between AR & HC (see Table).

Conclusion:

  • SREP seems to be based on central processes rather than to be related to peripheral sensitization.
  • SREP could be presented as a simple tool that would allow in a complementary way to explore the level of central pain sensitization in patients with chronic pain.
  • Potential clinical utility of SREP warrants further investigation.


Disclosure: M. Romero, None; S. Bruehl, None; G. A. Reyes del Paso, None; P. De la Coba, None.

To cite this abstract in AMA style:

Romero M, Bruehl S, Reyes del Paso GA, De la Coba P. Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/discriminating-between-central-peripheral-pain-sensitization-using-a-slowly-repeated-evoked-pain-protocol/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discriminating-between-central-peripheral-pain-sensitization-using-a-slowly-repeated-evoked-pain-protocol/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology